Skip to main content
SpringerLink
Log in

Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs)

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

Implantable cardioverter defibrillator (ICD) is a life-saving therapy for patients at risk of ventricular arrhythmias. Due to its high cost, its cost-effectiveness is highly dependent on its longevity, which is currently only based upon the manufacturer’s predicted device life span.

Aim

We sought to assess the ICDs’ longevity and the factors influencing it, and to compare the observed (real life) to the expected (manufacturer’s prediction) life span at a device level.

Methods

We retrospectively identified all patients who underwent an ICD implantation in a tertiary care medical center. For each device, an expected longevity was assigned based on the manufacturer/model, pacing percentage, and number of shocks per year. We defined device failure if the observed survival was shorter than 80 % of the expected. Only devices with follow-up time that exceeded the expected longevity were included.

Results

Of the 275 devices in the cohort, 79 (29 %) failed. Median device longevity was 5 years and varied markedly between manufacturers (4.3, 4.8, 5.1, and 6.3 years for Biotronik, St. Jude Medical, Boston Scientific, and Medtronic, respectively). There were significant differences among the manufacturers in device failure rates: 48, 17, 22, and 14 % for Biotronik, St. Jude Medical, Boston Scientific, and Medtronic, respectively). In multivariate analysis, manufacturer, earlier year of implantation, congestive heart failure and chronic renal failure significantly predicted device failure.

Conclusions

In conclusion, there is a significant device failure rate among ICDs, with variability among manufacturers, impacting both patients and the medical economic systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ICD:

Implantable cardioverter defibrillator

VVI:

Single chamber ICD

DDD:

Dual chamber ICD

CRT:

Cardiac resynchronization therapy bi-ventricular ICD

ERI:

Elective replacement indication

QALY:

Quality-adjusted life-years

References

  1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins ST, Klein H et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940

    Article  PubMed  CAS  Google Scholar 

  2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber D, Cannom DS et al (2002) Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  3. Kadish A, Dyer A, Daubert JP, Quigg R, Estes M, Anderson KP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158

    Article  PubMed  CAS  Google Scholar 

  4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes M, Freedman RA, Gettes LS et al (2008) ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 5:e1–e62

    Article  PubMed  Google Scholar 

  5. Sanders GD, Hlatky MA, Owens DK (2005) Cost-effectiveness of implantable cardioverter–defibrillators. N Engl J Med 353:1471–1480

    Article  PubMed  CAS  Google Scholar 

  6. Hauser RG (2005) The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J Am Coll Cardiol 45:2022–2025

    Article  PubMed  Google Scholar 

  7. Biffi M, Ziacchi M, Bertini M, Sangoirgi D, Corsini D, Martignan C et al (2008) Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 10:1288–1295

    Article  PubMed  Google Scholar 

  8. Ellinor PT, Guy ML, Ruskin JN, McGovern BA (2003) Variability in implantable cardioverter defibrillator pulse generator longevity between manufacturers. Pacing Clin Electrophysiol 26:71–75

    Article  PubMed  Google Scholar 

  9. Gepner K, Przybylski A, Maciag A, Sterliński M, Lewandowski M, Syska P et al (2007) Causes of redo procedures in patients with an implantable cardioverter-defibrillator—long-term follow-up results. Kardiol Pol 65:893–898

    PubMed  Google Scholar 

  10. Schaer BA, Koller MT, Sticherling C, Altmann D, Joerg L, Osswald S (2009) Longevity of implantable cardiovascular-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 6:1737–1743

    Article  PubMed  Google Scholar 

  11. Medtronic, Inc. (2011) Cardiac rhythm disease management product performance report: important patient management information for physicians. First edition, issue 64. Available at: http://wwwp.medtronic.com/productperformance-files/Issue64_MDT_CRDM_PPR_2011_1st_Edition.pdf

  12. St. Jude Medical (2011) Product performance report: cardiac rhythm management. Available at: http://www.sjmprofessional.com/Resources/product-performance-reports/Product-Performance-Report.aspx

  13. Boston Scientific (2011) CRM Product Performance Report Q2. Available at: http://www.bostonscientific.com/templatedata/imports/HTML/PPR/ppr/index.shtml

  14. Biotronik. Product Performance Report (2011). Available at: http://www.biotronik.com/sixcms/media.php/162/ppr_january_2011.13959.pdf

  15. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD et al (2006) The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol 47:2493–2497

    Article  PubMed  Google Scholar 

  16. Hauser RG, Hayes DL, Epstein AE, Cannom DS, Vlay SC, Song SL et al (2006) Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 3(6):640–644

    Article  PubMed  Google Scholar 

  17. FDA. Medical & Radiation Emitting Device Recalls. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?start_search=1&event_id=28982 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?start_search=1&event_id=27417 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=907751

  18. FDA. Medical & Radiation Emitting Device Recalls. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/resCollection_2.cfm?ID=39931&CREATE_DT=2005-06-30 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=40302 http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=37338

  19. Thijssen J, Borleffs CJ, Van Rees JB, Man S, De Bie MK, Venlet J, et al. (2011) Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. Heart Rhythm (Epub ahead of print)

  20. Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM et al (2011) Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 100(9):737–744

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Cardiology, Soroka University Medical Center, POB 151, 84101, Beer-Sheva, Israel

    Tali Shafat, Yuval Konstantino & Guy Amit

  2. Clinical Research Center, Soroka University Medical Center, Beer-Sheva, Israel

    Tali Shafat, Yael Baumfeld & Victor Novack

  3. Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

    Tali Shafat, Yael Baumfeld, Victor Novack, Yuval Konstantino & Guy Amit

Authors
  1. Tali Shafat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yael Baumfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victor Novack
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuval Konstantino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guy Amit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guy Amit.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 54 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shafat, T., Baumfeld, Y., Novack, V. et al. Significant differences in the expected versus observed longevity of implantable cardioverter defibrillators (ICDs). Clin Res Cardiol 102, 43–49 (2013). https://doi.org/10.1007/s00392-012-0493-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-012-0493-6

Keywords

Search

Navigation